Table 2 Association of LHR-I with demographics and disease characteristics
From: Expression of the luteinizing hormone receptor (LHR) in ovarian cancer
Factors | N | LHR Intensity | p-value* | |||
|---|---|---|---|---|---|---|
Negative | Weak | Moderate | Strong | |||
Age at Diagnosis | ||||||
< 60 | 130 | 21 (16%) | 15 (12%) | 16 (12%) | 78 (60%) | 0.22 |
≥ 60 | 102 | 9 (9%) | 9 (9%) | 10 (10%) | 74 (73%) | |
Serous Carcinoma | ||||||
No | 72 | 14 (19%) | 5 (7%) | 10 (14%) | 43 (60%) | 0.13 |
Yes | 160 | 16 (10%) | 19 (12%) | 16 (10%) | 109 (68%) | |
Pathologic Stage | ||||||
I/II | 68 | 13 (19%) | 8 (12%) | 13 (19%) | 34 (50%) | |
III/IV | 164 | 17 (10%) | 16 (10%) | 13 (8%) | 118 (72%) | |
Silberberg’s Grade | ||||||
1 | 27 | 7 (26%) | 3 (11%) | 2 (7%) | 15 (56%) | 0.21 |
2 or 3 | 205 | 23 (11%) | 21 (10%) | 24 (12%) | 137 (67%) | |
Persistent Disease | ||||||
No | 144 | 22 (15%) | 15 (10%) | 17 (12%) | 90 (63%) | 0.53 |
Yes | 88 | 8 (9%) | 9 (10%) | 9 (10%) | 62 (70%) | |